Metastatic Hormone Naive Prostate Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Metastatic Hormone Naive Prostate Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT03833921

Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostat…

The investigators are conducting this study with men that have prostate cancer and are getting standard of care treatment with the drugs abiraterone acetate and…

United States130 participantsStarted 2019-05-23

Treatment: Abiraterone Acetate, Prednisone

All recent trials (9 shown)

Active — Not RecruitingPhase 2

NCT03821792

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

This phase II trial studies how well abiraterone acetate, prednisone, and apalutamide work in treating patients with hormone-naive prostate cancer that has spre…

United States60 participantsStarted 2019-07-22

Treatment: Abiraterone Acetate, Apalutamide

Active — Not RecruitingPhase 2

NCT04343885

In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Ad…

This phase 2 randomised clinical trial will compare the effectiveness of Lu-PSMA therapy followed by docetaxel chemotherapy versus docetaxel chemotherapy on its…

Australia130 participantsStarted 2020-04-21

Treatment: 177Lu-PSMA-617, Docetaxel

Metastatic Hormone Naive Prostate Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostat…

All recent trials (9 shown)

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Ad…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostat…

All recent trials (9 shown)

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Ad…

A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newl…

Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer

A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer

Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer